General Atlantic has invested $55 million in Kalbe Genexine Biologics, an Indonesia-based drug developer focusing on Southeast Asia.
The company, also known as KGBio, is a joint venture between Kalbe Farma, a healthcare and pharmaceuticals company in Indonesia, and Genexine, a biotech developer in Korea. The plan is to combine Kalbe...
Invesco has led a USD 700m round for India-based on-demand delivery platform Swiggy at a reported valuation of USD 10.5bn.
BGH Capital has set the hard cap for its second Australia and New Zealand-focused fund at AUD 3.5bn (USD 2.5bn), having reached a first close of approximately AUD 3bn.
GLP, a regional logistics platform that makes private equity investments in ancillary businesses and technologies, has launched its debut Vietnam fund with USD 1.1bn in commitments.
Generation Asia Acquisition, a special purpose acquisition company (SPAC) sponsored by Roy Kuan, formerly Asia managing partner at CVC Capital Partners, has raised USD 200m through a US offering.